Hyperargininemia Clinical Trials

A listing of Hyperargininemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Stanford
Palo Alto California

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

District of Columbia

Children’s National
Washington District of Columbia

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

Florida

University of Florida
Gainesville Florida

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

View More ▼

Gainesville Florida

A clinical research study of AEB1102 for the treatment of Arginase I Deficiency or Hyperargininemia

Michigan

Children’s Hospital of Michigan
Detroit Michigan

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

New York

Mt. Sinai
New York New York

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

View More ▼

New York New York

A clinical research study of AEB1102 for the treatment of Arginase I Deficiency or Hyperargininemia

Pennsylvania

Children’s Hospital of Pittsburgh
Pittsburgh Pennsylvania

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

Texas

University of Texas Southwestern
Dallas Texas

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

Utah

University of Utah
Salt Lake City Utah

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

Washington

Seattle Children’s Hospital
Seattle Washington

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102

Canada

SickKids
Toronto International

A Phase 1/2 Open-Label Study in Patients with Arginase I Deficiency to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous AEB1102